» Articles » PMID: 24007715

Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers Among Adults Living Near a Chemical Plant

Overview
Date 2013 Sep 7
PMID 24007715
Citations 183
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Perfluorooctanoic acid (PFOA) is a synthetic chemical ubiquitous in the serum of U.S. residents. It causes liver, testicular, and pancreatic tumors in rats. Human studies are sparse.

Objective: We examined cancer incidence in Mid-Ohio Valley residents exposed to PFOA in drinking water due to chemical plant emissions.

Methods: The cohort consisted of adult community residents who resided in contaminated water districts or worked at a local chemical plant. Most participated in a 2005-2006 baseline survey in which serum PFOA was measured. We interviewed the cohort in 2008-2011 to obtain further medical history. Retrospective yearly PFOA serum concentrations were estimated for each participant from 1952 through 2011. Self-reported cancers were validated through medical records and cancer registry review. We estimated the association between cancer and cumulative PFOA serum concentration using proportional hazards models.

Results: Participants (n = 32,254) reported 2,507 validated cancers (21 different cancer types). Estimated cumulative serum PFOA concentrations were positively associated with kidney and testicular cancer [hazard ratio (HR) = 1.10; 95% CI: 0.98, 1.24 and HR = 1.34; 95% CI: 1.00, 1.79, respectively, for 1-unit increases in ln-transformed serum PFOA]. Categorical analyses also indicated positive trends with increasing exposures for both cancers: for kidney cancer HRs for increasing exposure quartiles were 1.0, 1.23, 1.48, and 1.58 (linear trend test p = 0.18) and for testicular cancer, HRs were 1.0, 1.04, 1.91, 3.17 (linear trend test p = 0.04).

Conclusions: PFOA exposure was associated with kidney and testicular cancer in this population. Because this is largely a survivor cohort, findings must be interpreted with caution, especially for highly fatal cancers such as pancreatic and lung cancer.

Citing Articles

The impact of anions on electrooxidation of perfluoroalkyl acids by porous Magnéli phase titanium suboxide anodes.

Wang Y, Wang Y, Dong S, Huang Q PLoS One. 2025; 20(1):e0317696.

PMID: 39847564 PMC: 11756806. DOI: 10.1371/journal.pone.0317696.


Enhanced spatial analysis assessing the association between PFAS-contaminated water and cancer incidence: rationale, study design, and methods.

Jones R, Kulick E, Snead R, Wilson R, Hughes J, Lillys T BMC Cancer. 2025; 25(1):101.

PMID: 39833723 PMC: 11744822. DOI: 10.1186/s12885-025-13508-2.


Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident cancer burden attributable to PFAS in drinking water in the United States.

Li S, Oliva P, Zhang L, Goodrich J, McConnell R, Conti D J Expo Sci Environ Epidemiol. 2025; .

PMID: 39789195 DOI: 10.1038/s41370-024-00742-2.


Per- And Poly-Fluoroalkyl Substances (PFAS) Exposure and Risk of Breast, and Female Genital Cancers: A Systematic Review and Meta-Analysis.

Seyyedsalehi M, Maria Kappil E, Zhang S, Zheng T, Boffetta P Med Lav. 2024; 115(6):e2024043.

PMID: 39697081 PMC: 11734636. DOI: 10.23749/mdl.v115i6.16330.


Toxic layering and compound extremes: Per- and polyfluoroalkyl substances (PFAS) exposure in rural, environmental justice copper mining communities.

Chukwuonye G, Alqattan Z, Jones M, Jones C, Brusseau M, Ramirez-Andreotta M Sci Total Environ. 2024; 957:177767.

PMID: 39631327 PMC: 11661929. DOI: 10.1016/j.scitotenv.2024.177767.


References
1.
Frisbee S, Brooks Jr A, Maher A, Flensborg P, Arnold S, Fletcher T . The C8 health project: design, methods, and participants. Environ Health Perspect. 2010; 117(12):1873-82. PMC: 2799461. DOI: 10.1289/ehp.0800379. View

2.
Kennedy Jr G, Butenhoff J, Olsen G, OConnor J, Seacat A, Perkins R . The toxicology of perfluorooctanoate. Crit Rev Toxicol. 2004; 34(4):351-84. DOI: 10.1080/10408440490464705. View

3.
Armstrong B . Effect of measurement error on epidemiological studies of environmental and occupational exposures. Occup Environ Med. 1999; 55(10):651-6. PMC: 1757516. DOI: 10.1136/oem.55.10.651. View

4.
Olsen G, Burris J, Ehresman D, Froehlich J, Seacat A, Butenhoff J . Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect. 2007; 115(9):1298-305. PMC: 1964923. DOI: 10.1289/ehp.10009. View

5.
Shin H, Vieira V, Ryan P, Steenland K, Bartell S . Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ Health Perspect. 2011; 119(12):1760-5. PMC: 3261988. DOI: 10.1289/ehp.1103729. View